Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Robert, Caroline, Grob, Jean J., Stroyakovskiy, Daniil, Karaszewska, Boguslawa, Hauschild, Axel, Levchenko, Evgeny, Chiarion Sileni, Vanna, Schachter, Jacob, Garbe, Claus, Bondarenko, Igor, Gogas, HelLanguage:
english
Journal:
New England Journal of Medicine
DOI:
10.1056/NEJMoa1904059
Date:
June, 2019
File:
PDF, 379 KB
english, 2019